Literature DB >> 23247586

Elevated lipoprotein(a) in a newborn with thrombosis and a family history of dyslipidemia.

Nathalie Jeanne Magioli Bravo-Valenzuela1.   

Abstract

This paper reports a rare case of elevated lipoproteinemia(a) that evolved into thrombosis during the neonatal period. During the first days of life, the patient presented with an intracardiac thrombus, pulmonary thromboembolism and a hemorrhagic stroke. Initially, the results of the blood tests performed to screen for thrombophilic diseases were normal for the patient's age. The maternal dyslipidemia and the family's positive history of thromboembolism drew attention to an underlying, inherited, thrombophilic defect. Upon further investigation of the thrombophilia, the increase in lipoprotein(a) levels found in the mother and infant enabled the diagnosis of hyperlipoprotein(a) and the administration of appropriate therapy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23247586     DOI: 10.1007/s00246-012-0610-3

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  11 in total

1.  Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Paul Monagle; Anthony K C Chan; Neil A Goldenberg; Rebecca N Ichord; Janna M Journeycake; Ulrike Nowak-Göttl; Sara K Vesely
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  The investigation and management of neonatal haemostasis and thrombosis.

Authors:  Michael D Williams; Elizabeth A Chalmers; Brenda E S Gibson
Journal:  Br J Haematol       Date:  2002-11       Impact factor: 6.998

Review 3.  Inhibition of fibrinolysis by lipoprotein(a).

Authors:  E Anglés-Cano; A de la Peña Díaz; S Loyau
Journal:  Ann N Y Acad Sci       Date:  2001       Impact factor: 5.691

4.  Lipoprotein (a): its role in childhood thromboembolism.

Authors:  U Nowak-Göttl; O Debus; M Findeisen; R Kassenböhmer; H G Koch; H Pollmann; C Postler; P Weber; H Vielhaber
Journal:  Pediatrics       Date:  1997-06       Impact factor: 7.124

5.  An open-label randomized controlled trial of low molecular weight heparin compared to heparin and coumadin for the treatment of venous thromboembolic events in children: the REVIVE trial.

Authors:  Patricia Massicotte; Jim A Julian; Michael Gent; Karen Shields; Velma Marzinotto; Barbara Szechtman; Maureen Andrew
Journal:  Thromb Res       Date:  2003-01-25       Impact factor: 3.944

Review 6.  Venous thromboembolism in the neonatal period.

Authors:  Diana S Beardsley
Journal:  Semin Perinatol       Date:  2007-08       Impact factor: 3.300

Review 7.  Thrombosis in children: current perspective and distinct challenges.

Authors:  Matthew W Richardson; Geoffrey A Allen; Paul E Monahan
Journal:  Thromb Haemost       Date:  2002-12       Impact factor: 5.249

Review 8.  Percutaneous central venous catheters versus peripheral cannulae for delivery of parenteral nutrition in neonates.

Authors:  S B Ainsworth; L Clerihew; W McGuire
Journal:  Cochrane Database Syst Rev       Date:  2007-07-18

9.  Effect of aspirin treatment on serum concentrations of lipoprotein(a) in patients with atherosclerotic diseases.

Authors:  Masashi Akaike; Hiroyuki Azuma; Ayako Kagawa; Kazuya Matsumoto; Ikuro Hayashi; Katsuya Tamura; Takeshi Nishiuchi; Takahiko Iuchi; Nobuyuki Takamori; Ken-ichi Aihara; Tomonori Yoshida; Yasuhiko Kanagawa; Toshio Matsumoto
Journal:  Clin Chem       Date:  2002-09       Impact factor: 8.327

Review 10.  Thrombosis in the critically ill neonate: incidence, diagnosis, and management.

Authors:  Alex Veldman; Marcel F Nold; Ina Michel-Behnke
Journal:  Vasc Health Risk Manag       Date:  2008
View more
  1 in total

1.  Interactions between genetic variants involved in the folate metabolic pathway and serum lipid, homocysteine levels on the risk of recurrent spontaneous abortion.

Authors:  Zhong Lin; Qianxi Li; Yifan Sun; Jingchun Huang; Wan Wang; Jinjian Fu; Jianhua Xu; Dingyuan Zeng
Journal:  Lipids Health Dis       Date:  2019-06-15       Impact factor: 3.876

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.